Select a medication above to begin.
levonorgestrel/ ethinyl estradiol
generic
Black Box Warnings .
Smoking and Cardiovascular Events
cigarette smoking incr. risk of serious cardiovascular events from combined hormonal contraceptive use; incr. risk w/ age (particularly for patients >35 yo) and w/ number of cigarettes smoked; contraindicated in smokers >35 yo
Adult Dosing .
Dosage forms: 20 mcg EE 28-day monophasic pack; 20 mcg EE 28-day continuous monophasic pack; 30 mcg EE 28-day monophasic pack; 30 mcg EE 91-day monophasic pack; 20 mcg EE 91-day biphasic pack; 30 mcg EE 91-day biphasic pack; 28-day triphasic pack; 91-day quadriphasic pack
Dosage Form Details
- [20 mcg EE 28-day monophasic pack]
- Info: 0.1 mg/20 mcg x21 and inert tab x7
- [20 mcg EE 28-day continuous monophasic pack]
- Info: 0.09 mg/20 mcg x28
- [30 mcg EE 28-day monophasic pack]
- Info: 0.15 mg/30 mcg x21 and inert tab x7
- [30 mcg EE 91-day monophasic pack]
- Info: 0.15 mg/30 mcg x84 and inert tab x7
- [20 mcg EE 91-day biphasic pack]
- Info: 0.1 mg/20 mcg x84 and 0 mg/10 mcg x7
- [30 mcg EE 91-day biphasic pack]
- Info: 0.15 mg/30 mcg x84 and 0 mg/10 mcg x7
- [28-day triphasic pack]
- Info: 0.05 mg/30 mcg x6, 0.075 mg/40 mcg x5, 0.125 mg/30 mcg x10, and inert tab x7
- [91-day quadriphasic pack]
- Info: 0.15 mg/20 mcg x42, 0.15 mg/25 mcg x21, 0.15 mg/30 mcg x21, and 0 mg/10 mcg x7
Special Note
- [additional info]
- Info: see Oral Contraceptive Pill (OCP) Hormonal Activity and Therapeutic Equivalence table
contraception
- [28-day monophasic or triphasic pack]
- Dose: 1 tab PO qd; Start: day 1 of menstrual cycle or 1st Sunday after onset of menses; Info: D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding
- [28-day continuous monophasic pack]
- Dose: 1 tab PO qd; Start: day 1 of menstrual cycle; Info: D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding
- [91-day monophasic, biphasic, or quadriphasic pack]
- Dose: 1 tab PO qd; Start: 1st Sunday after onset of menses; Info: D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding
dysfunctional uterine bleeding, moderate (off-label)
- [30 mcg EE monophasic pack, acute phase]
- Dose: 1 tab PO bid x5-7 days, then 1 tab PO qd until all active tabs given in 1 pack, skip inert tabs; Alt: 1 tab PO tid x3 days or until bleeding subsides, then 1 tab PO bid x3-5 days, then 1 tab PO qd until all active tabs given in 1 pack, skip inert tabs
- [30 mcg EE monophasic pack, maintenance phase]
- Dose: 1 tab PO qd; Info: may skip inert tabs for continuous cycle; D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding
dysmenorrhea (off-label)
- [28-day monophasic or triphasic pack]
- Dose: 1 tab PO qd; Start: day 1 of menstrual cycle or 1st Sunday after onset of menses; Info: may skip inert tabs for extended or continuous cycle if pain persists; D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding
- [28-day continuous monophasic pack]
- Dose: 1 tab PO qd; Start: day 1 of menstrual cycle; Info: D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding
- [91-day monophasic, biphasic, or quadriphasic pack]
- Dose: 1 tab PO qd; Start: 1st Sunday after onset of menses; Info: may skip inert tabs for continuous cycle if pain persists; D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding
emergency contraception (off-label)
- [20 mcg EE monophasic, biphasic, or quadriphasic pack]
- Dose: 5 tabs PO q12h x2 doses; Start: ASAP after unprotected intercourse; maximum efficacy w/in 72h, moderate efficacy w/in 120h; Info: use levonorgestrel/ethinyl estradiol 0.1 mg/20 mcg tabs or 0.15 mg/20 mcg tabs; repeat dose if vomiting occurs w/in 3h
- [20 mcg EE continuous monophasic pack]
- Dose: 6 tabs PO q12h x2 doses; Start: ASAP after unprotected intercourse; maximum efficacy w/in 72h, moderate efficacy w/in 120h; Info: repeat dose if vomiting occurs w/in 3h
- [25 mcg or 30 mcg EE-containing pack]
- Dose: 4 tabs PO q12h x2 doses; Start: ASAP after unprotected intercourse; maximum efficacy w/in 72h, moderate efficacy w/in 120h; Info: use levonorgestrel/ethinyl estradiol 0.15 mg/25 mcg, 0.125 mg/30 mcg, or 0.15 mg/30 mcg tabs; repeat dose if vomiting occurs w/in 3h
endometriosis (off-label)
- [28-day monophasic or triphasic pack]
- Dose: 1 tab PO qd; Start: day 1 of menstrual cycle or 1st Sunday after onset of menses; Info: may skip inert tabs for extended or continuous cycle if pain persists; D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding
- [28-day continuous monophasic pack]
- Dose: 1 tab PO qd; Start: day 1 of menstrual cycle; Info: D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding
- [91-day monophasic, biphasic, or quadriphasic pack]
- Dose: 1 tab PO qd; Start: 1st Sunday after onset of menses; Info: may skip inert tabs for continuous cycle if pain persists; D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding
renal dosing
- [see below]
- renal dz: not defined, caution advised
- HD/PD: avoid use
hepatic dosing
- [see below]
- active hepatic dz: contraindicated
Peds Dosing .
- Dosage forms: 20 mcg EE 28-day monophasic pack; 20 mcg EE 28-day continuous monophasic pack; 30 mcg EE 28-day monophasic pack; 30 mcg EE 91-day monophasic pack; 20 mcg EE 91-day biphasic pack; 30 mcg EE 91-day biphasic pack; 28-day triphasic pack; 91-day quadriphasic pack
Dosage Form Details
- [20 mcg EE 28-day monophasic pack]
- Info: 0.1 mg/20 mcg x21 and inert tab x7
- [20 mcg EE 28-day continuous monophasic pack]
- Info: 0.09 mg/20 mcg x28
- [30 mcg EE 28-day monophasic pack]
- Info: 0.15 mg/30 mcg x21 and inert tab x7
- [30 mcg EE 91-day monophasic pack]
- Info: 0.15 mg/30 mcg x84 and inert tab x7
- [20 mcg EE 91-day biphasic pack]
- Info: 0.1 mg/20 mcg x84 and 0 mg/10 mcg x7
- [30 mcg EE 91-day biphasic pack]
- Info: 0.15 mg/30 mcg x84 and 0 mg/10 mcg x7
- [28-day triphasic pack]
- Info: 0.05 mg/30 mcg x6, 0.075 mg/40 mcg x5, 0.125 mg/30 mcg x10, and inert tab x7
- [91-day quadriphasic pack]
- Info: 0.15 mg/20 mcg x42, 0.15 mg/25 mcg x21, 0.15 mg/30 mcg x21, and 0 mg/10 mcg x7
Special Note
- [additional info]
- Info: see Oral Contraceptive Pill (OCP) Hormonal Activity and Therapeutic Equivalence table
contraception
- [28-day monophasic or triphasic pack, postmenarchal patients]
- Dose: 1 tab PO qd; Start: day 1 of menstrual cycle or 1st Sunday after onset of menses; Info: D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding
- [28-day continuous monophasic pack, postmenarchal patients]
- Dose: 1 tab PO qd; Start: day 1 of menstrual cycle; Info: D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding
- [91-day monophasic, biphasic, or quadriphasic pack, postmenarchal patients]
- Dose: 1 tab PO qd; Start: 1st Sunday after onset of menses; Info: D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding
dysfunctional uterine bleeding, moderate (off-label)
- [30 mcg EE monophasic pack, acute phase, postmenarchal patients]
- Dose: 1 tab PO bid x5-7 days, then 1 tab PO qd until all active tabs given in 1 pack, skip inert tabs; Alt: 1 tab PO tid x3 days or until bleeding subsides, then 1 tab PO bid x3-5 days, then 1 tab PO qd until all active tabs given in 1 pack, skip inert tabs
- [30 mcg EE monophasic pack, maintenance phase, postmenarchal patients]
- Dose: 1 tab PO qd; Info: may skip inert tabs for continuous cycle; D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding
dysmenorrhea (off-label)
- [28-day monophasic or triphasic pack, postmenarchal patients]
- Dose: 1 tab PO qd; Start: day 1 of menstrual cycle or 1st Sunday after onset of menses; Info: may skip inert tabs for extended or continuous cycle if pain persists; D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding
- [28-day continuous monophasic pack, postmenarchal patients]
- Dose: 1 tab PO qd; Start: day 1 of menstrual cycle; Info: D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding
- [91-day monophasic, biphasic, or quadriphasic pack, postmenarchal patients]
- Dose: 1 tab PO qd; Start: 1st Sunday after onset of menses; Info: may skip inert tabs for continuous cycle if pain persists; D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding
emergency contraception (off-label)
- [20 mcg EE monophasic, biphasic, or quadriphasic pack, postmenarchal patients]
- Dose: 5 tabs PO q12h x2 doses; Start: ASAP after unprotected intercourse; maximum efficacy w/in 72h, moderate efficacy w/in 120h; Info: use levonorgestrel/ethinyl estradiol 0.1 mg/20 mcg tabs or 0.15 mg/20 mcg tabs; repeat dose if vomiting occurs w/in 3h
- [20 mcg EE continuous monophasic pack, postmenarchal patients]
- Dose: 6 tabs PO q12h x2 doses; Start: ASAP after unprotected intercourse; maximum efficacy w/in 72h, moderate efficacy w/in 120h; Info: repeat dose if vomiting occurs w/in 3h
- [25 mcg or 30 mcg EE-containing pack, postmenarchal patients]
- Dose: 4 tabs PO q12h x2 doses; Start: ASAP after unprotected intercourse; maximum efficacy w/in 72h, moderate efficacy w/in 120h; Info: use levonorgestrel/ethinyl estradiol 0.15 mg/25 mcg, 0.125 mg/30 mcg, or 0.15 mg/30 mcg tabs; repeat dose if vomiting occurs w/in 3h
endometriosis (off-label)
- [28-day monophasic or triphasic pack, postmenarchal patients]
- Dose: 1 tab PO qd; Start: day 1 of menstrual cycle or 1st Sunday after onset of menses; Info: may skip inert tabs for extended or continuous cycle if pain persists; D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding
- [28-day continuous monophasic pack, postmenarchal patients]
- Dose: 1 tab PO qd; Start: day 1 of menstrual cycle; Info: D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding
- [91-day monophasic, biphasic, or quadriphasic pack, postmenarchal patients]
- Dose: 1 tab PO qd; Start: 1st Sunday after onset of menses; Info: may skip inert tabs for continuous cycle if pain persists; D/C >4wk before, restart >2wk after surgery w/ VTE risk; restart >4wk postpartum or >6wk postpartum if breastfeeding
renal dosing
- [see below]
- renal dz: not defined, caution advised
- HD/PD: avoid use
hepatic dosing
- [see below]
- active hepatic dz: contraindicated